ONC212 is a novel compound under investigation for its potential in cancer therapy, particularly due to its ability to modulate specific signaling pathways involved in tumor cell survival and proliferation. It has shown selective activity against certain cancer cell lines by inducing apoptosis and inhibiting key oncogenic mechanisms. Research suggests it may enhance the effectiveness of other anticancer agents, making it a candidate for combination therapies. Its application is primarily focused in preclinical oncology research, where it serves as a tool compound to study tumor biology and therapeutic response. Further development may explore its use in targeted treatments for resistant or aggressive cancers.